WELCOME TO THE FIRST DAY OF THE HOW I MANAGE CAR-T THERAPIES AND BISPECIFIC ANTIBODIES FOR MY PATIENTS E-CONFERENCE

How I Manage

CAR-T Therapies and Bispecific Antibodies

for my Patients

  Chairs: Peter Borchmann, Ulrich Jäger, Marie José Kersten 

September 6-9, 2021- E-Conference

FREE REGISTRATION

 

 

---

JOIN US FOR THE FIRST DAY OF THE E-CONFERENCE:
STARTING TODAY, SEPTEMBER 6th AT 14:40 CEST

Highlights of Day 1 Full programme

---

WELCOME MESSAGE FROM THE E-CONFERENCE CHAIRPERSONS

   

---

ALREADY REGISTERED?

 

Click here to access the on-demand programme

Click here to also register for a Meet the Expert session

(more information below)

---

TO MEET THE FACULTY, CLICK HERE

---

- Diffuse large B-cell Lymphoma: How to optimize the benefit of CAR T-cell therapy?

- Diffuse large B-cell Lymphoma: How to minimize potential risks of CAR T-cell therapy?

- Bispecific antibodies in the treatment of B-NHL

- Multiple Myeloma: targeting BCMA with bispecifics and CARs

- Acute lymphoblastic leukaemia: the role of CARs and bispecifics - lessons from paediatric haematology

- Perspectives: CARs and bispecifics for haematological malignancies

 

---

ABOUT THE CONFERENCE

About the programme:
CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies.

The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants.

In addition to the scientific and medical issues addressed during the conference, the questions of affordability of and access to these novel expensive treatments will be tackled by medical experts, representatives of patient organisations, economists, authorities and industry.

Learning objectives:
Upon completion of this CME activity, participants should have improved understanding of:
1.  the current landscape of CAR-T cells and bispecific antibodies
2.  novel approaches and technologies in the field
3.  how to integrate these novel therapies into current clinical practice
4.  future perspectives in bispecific antibody and cellular therapies in haematological malignancies and solid tumours.

---

To access the final programme, click here

 

TIMING OF THE SCIENTIFIC PROGRAMME:

Participants will be joining us from all over the world and from different time zones.

To make sure that everyone has access to the full scientific programme at a convenient hour, registration will allow participants to join both the LIVE PROGRAMME (September 6-9, 2021) and the PROGRAMME ON DEMAND (August 27 - October 9, 2021).

The “Live Programme”  will be streamed live CEST time.  It will include Meet the Expert sessions, interactive panel discussions, Q&A periods and Mentored Poster Walks. It will also include some pre-recorded lectures that will be streamed live, followed by their corresponding fully live Q&A period.

The “Programme on-Demand”  is available as of August 27, 2021.
It will initially include the pre-recorded components of the scientific programme.
It will be progressively enriched by the meeting’s live, interactive components which will be recorded real time during the meeting.

E-POSTERS: August 27 - October 9, 2021
The Poster Hall will also remain open until October 9, 2021. The Mentored Poster Walks scheduled in the LIVE PROGRAMME will also become available in the PROGRAMME ON DEMAND.

VIRTUAL EXHIBITION: August 27 - October 9, 2021
We invite you to visit the Exhibition area as of August 27.
Our corporate partners will be pleased to welcome & chat with you.

---

MEET THE EXPERT PROGRAMME

 

 

---

"Neuroblastoma" with Franco Locatelli (Rome)
Join us live on Tuesday, September 7th at 19:00 CEST!




"Making CAR T-cells last" with Karin Straathof (London)
Join us live on Tuesday, September 7th at 19:00 CEST!




"Sleeping Beauty" with Michael Hudecek (Würzburg)
Join us live on Wednesday, September 8th at 18:50 CEST!




"Point of care production of CAR T-cells" with Alvaro Urbano-Ispizua (Barcelona)
Join us live on Wednesday, September 8th at 18:50 CEST!

 

MORE INFORMATION

---

With the support of*:

 

 

Major E-Conference Partners

*******

 

 

Supporting E-Conference Partner

*******

 

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.